文献速递腹部妇产影像CTMRPET

卵巢癌腹膜播散的最新影像学评估:放射科医生如何辅助制定治疗方案

State of the art imaging in ovarian carcinomatosis: how the radiologist can help plan management.
PubMed 文献 · Clin Radiol · 2026-08-19

本文综述了CT、MRI和PET在晚期卵巢癌腹膜病变评估中的证据。CT是分期一线手段,但对小体积种植和复杂区域受累敏感度较低;MRI通过弥散加权和增强技术提高腹膜、肠浆膜及膈下病变检出;PET/CT可补充代谢信息。影像学进步和放射科医生专业判断有助于优化手术规划及多学科管理。

要点

  • CT是晚期卵巢癌分期一线影像,用于评估腹膜、淋巴结及腹外病变。
  • MRI弥散加权和增强序列可提高肠浆膜、肠系膜及膈下腹膜病变检出。
  • 影像评估重点在于判断不可切除征象,辅助选择初次减灭术或新辅助化疗。

关键影像表现/征象

  • 高级别浆液性癌常表现为广泛腹膜播散,术前准确评估疾病分布对治疗选择至关重要。
  • CT对小体积种植和手术复杂区域受累的敏感度降低。
  • MRI软组织表征更优,尤其通过弥散加权和增强技术改善肠浆膜、肠系膜及膈下间隙腹膜病变检出。
  • PET/CT提供代谢信息,在特定病例中可增强淋巴结和腹膜外转移检出。
  • 影像组学和机器学习等定量技术有望提取影像生物标志物,辅助预测可切除性和复发风险分层。

临床应用与阅片要点

  • 阅片时应系统评估腹膜、淋巴结及腹外病变分布,识别提示不可切除的特征。
  • 对CT怀疑小体积腹膜种植或复杂区域受累者,可考虑MRI弥散加权和增强序列补充评估。
  • 影像评估结果应纳入多学科讨论,辅助选择初次减灭术或新辅助化疗后间隔减灭术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ovarian cancer (OC) is the leading cause of gynaecological cancer mortality and is most often diagnosed at an advanced stage due to its subtle early clinical presentation and characteristic peritoneal dissemination. High-grade serous carcinoma represents the predominant epithelial subtype and frequently presents with extensive peritoneal disease, making accurate preoperative evaluation essential. Management of advanced OC (AOC) hinges on the selection of patients for primary cytoreductive surgery vs neoadjuvant chemotherapy followed by interval cytoreduction, with complete cytoreduction remaining the strongest prognostic factor. Radiologists therefore play a critical role in assessing disease distribution, identifying features suggestive of unresectability, and guiding multidisciplinary decision-making. Contrast-enhanced computed tomography (CT) is the first-line modality for staging AOC, providing comprehensive assessment of peritoneal, nodal, and extra-abdominal disease. Despite its established utility, CT has reduced sensitivity for small-volume implants and involvement in surgically complex regions. Magnetic resonance imaging (MRI) offers superior soft tissue characterisation and improves detection of peritoneal disease along the bowel serosa, mesentery, and subdiaphragmatic spaces, particularly through diffusion-weighted and contrast-enhanced techniques. Positron emission tomography (PET)/CT provides complementary metabolic information that can enhance detection of nodal and extraperitoneal metastases in selected cases. Emerging quantitative techniques, including radiomics and machine learning-based analysis, have the potential to extract biologically relevant imaging biomarkers, refine predictions of resectability, and stratify recurrence risk. Integrating these tools with conventional imaging may further support personalised treatment pathways. This review summarises current evidence regarding CT, MRI, and PET in the evaluation of peritoneal disease in AOC and highlights how imaging advances and radiologist expertise can optimise surgical planning and guide management strategies.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Qin C, Chiu S, Bharwani N, et al. State of the art imaging in ovarian carcinomatosis: how the radiologist can help plan management. Clin Radiol. 2026. PMID: 42914934. doi:10.1016/j.crad.2026.107460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。